Bay Area biotech’s $100M investment in Oregon is on track


The South San Francisco-based maker of synthetic DNA plans to be in operation in the Portland area by January.

Previous PPP loan forgiveness trudges ahead, pushed by 2021 activity
Next Common Ground now offers farm tours to highlight regenerative ag